[Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?]
Vnitr Lek
.
1974 Sep;20(8):741-5.
[Article in Slovak]
Authors
V Cerný
,
I Koza
,
J Hal'ko
,
L Bohunický
,
Z Krizan
,
L Poliaková
,
C Petrek
,
S Korec
PMID:
4527291
No abstract available
Publication types
English Abstract
MeSH terms
Antibody Formation
Antineoplastic Agents / therapeutic use*
Evaluation Studies as Topic
Humans
Leukemia, Myeloid / drug therapy*
Leukemia, Myeloid / immunology
Remission, Spontaneous
Substances
Antineoplastic Agents